{"id":"https://openalex.org/W3216831771","doi":"https://doi.org/10.3389/fonc.2021.751391","title":"Lenvatinib Plus PD-1 Inhibitors as First-Line Treatment in Patients With Unresectable Biliary Tract Cancer: A Single-Arm, Open-Label, Phase II Study","display_name":"Lenvatinib Plus PD-1 Inhibitors as First-Line Treatment in Patients With Unresectable Biliary Tract Cancer: A Single-Arm, Open-Label, Phase II Study","alternate_titles":[],"publication_year":2021,"publication_date":"2021-11-24","ids":{"openalex":"https://openalex.org/W3216831771","doi":"https://doi.org/10.3389/fonc.2021.751391","mag":"3216831771","pmid":"https://pubmed.ncbi.nlm.nih.gov/34900698","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8651538"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2021.751391","doi":"https://doi.org/10.3389/fonc.2021.751391","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2021.751391","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3216831771"],"child_works_count":1,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fonc.2021.751391","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Qiyi Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158318","display_name":"Second Affiliated Hospital of Zhejiang University","ror":"https://ror.org/059cjpv64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210158318"]},{"id":"https://openalex.org/I76130692","display_name":"Zhejiang University","ror":"https://ror.org/00a2xv884","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qiyi Zhang","raw_affiliation_strings":["Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China","Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China","institution_ids":["https://openalex.org/I4210158318","https://openalex.org/I76130692"]},{"raw_affiliation_string":"Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100435055","display_name":"Xingyu Liu","orcid":"https://orcid.org/0009-0003-3815-4953","observed_orcids":["https://orcid.org/0009-0003-3815-4953"]},"institutions":[{"id":"https://openalex.org/I4210158318","display_name":"Second Affiliated Hospital of Zhejiang University","ror":"https://ror.org/059cjpv64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210158318"]},{"id":"https://openalex.org/I76130692","display_name":"Zhejiang University","ror":"https://ror.org/00a2xv884","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xingyu Liu","raw_affiliation_strings":["Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China","Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China","institution_ids":["https://openalex.org/I4210158318","https://openalex.org/I76130692"]},{"raw_affiliation_string":"Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015743363","display_name":"Shumei Wei","orcid":"https://orcid.org/0009-0003-6254-0918","observed_orcids":["https://orcid.org/0009-0003-6254-0918"]},"institutions":[{"id":"https://openalex.org/I4210158318","display_name":"Second Affiliated Hospital of Zhejiang University","ror":"https://ror.org/059cjpv64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210158318"]},{"id":"https://openalex.org/I76130692","display_name":"Zhejiang University","ror":"https://ror.org/00a2xv884","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shumei Wei","raw_affiliation_strings":["Department of Pathology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China","institution_ids":["https://openalex.org/I4210158318","https://openalex.org/I76130692"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016405348","display_name":"Lufei Zhang","orcid":"https://orcid.org/0000-0002-6270-0737","observed_orcids":["https://orcid.org/0000-0002-6270-0737"]},"institutions":[{"id":"https://openalex.org/I4210158318","display_name":"Second Affiliated Hospital of Zhejiang University","ror":"https://ror.org/059cjpv64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210158318"]},{"id":"https://openalex.org/I76130692","display_name":"Zhejiang University","ror":"https://ror.org/00a2xv884","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lufei Zhang","raw_affiliation_strings":["Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China","Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China","institution_ids":["https://openalex.org/I4210158318","https://openalex.org/I76130692"]},{"raw_affiliation_string":"Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104258776","display_name":"Yang Tian","orcid":"https://orcid.org/0009-0003-3043-3413","observed_orcids":["https://orcid.org/0009-0003-3043-3413"]},"institutions":[{"id":"https://openalex.org/I4210158318","display_name":"Second Affiliated Hospital of Zhejiang University","ror":"https://ror.org/059cjpv64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210158318"]},{"id":"https://openalex.org/I76130692","display_name":"Zhejiang University","ror":"https://ror.org/00a2xv884","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yang Tian","raw_affiliation_strings":["Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China","Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China","institution_ids":["https://openalex.org/I4210158318","https://openalex.org/I76130692"]},{"raw_affiliation_string":"Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046841780","display_name":"Zhenzhen Gao","orcid":"https://orcid.org/0000-0002-9525-0568","observed_orcids":["https://orcid.org/0000-0002-9525-0568"]},"institutions":[{"id":"https://openalex.org/I4210158318","display_name":"Second Affiliated Hospital of Zhejiang University","ror":"https://ror.org/059cjpv64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210158318"]},{"id":"https://openalex.org/I76130692","display_name":"Zhejiang University","ror":"https://ror.org/00a2xv884","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhenzhen Gao","raw_affiliation_strings":["Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China","Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China","institution_ids":["https://openalex.org/I4210158318","https://openalex.org/I76130692"]},{"raw_affiliation_string":"Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ming Jin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158318","display_name":"Second Affiliated Hospital of Zhejiang University","ror":"https://ror.org/059cjpv64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210158318"]},{"id":"https://openalex.org/I76130692","display_name":"Zhejiang University","ror":"https://ror.org/00a2xv884","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ming Jin","raw_affiliation_strings":["Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China","Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China","institution_ids":["https://openalex.org/I4210158318","https://openalex.org/I76130692"]},{"raw_affiliation_string":"Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078744722","display_name":"Sheng\u2010Lei Yan","orcid":"https://orcid.org/0000-0003-4305-8520","observed_orcids":["https://orcid.org/0000-0003-4305-8520"]},"institutions":[{"id":"https://openalex.org/I4210158318","display_name":"Second Affiliated Hospital of Zhejiang University","ror":"https://ror.org/059cjpv64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210158318"]},{"id":"https://openalex.org/I76130692","display_name":"Zhejiang University","ror":"https://ror.org/00a2xv884","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Sheng Yan","raw_affiliation_strings":["Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China","Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China","institution_ids":["https://openalex.org/I4210158318","https://openalex.org/I76130692"]},{"raw_affiliation_string":"Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, China","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5078744722"],"corresponding_institution_ids":["https://openalex.org/I4210158318","https://openalex.org/I76130692"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":13.0646,"has_fulltext":true,"cited_by_count":85,"citation_normalized_percentile":{"value":0.99448889,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"11","issue":null,"first_page":"751391","last_page":"751391"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12460","display_name":"Pediatric Hepatobiliary Diseases and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lenvatinib","display_name":"lenvatinib","score":0.9800000190734863},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/biliary-tract-cancer","display_name":"biliary tract cancer","score":0.9639999866485596},{"id":"https://openalex.org/keywords/unresectable-biliary-tract-cancer","display_name":"unresectable biliary tract cancer","score":0.7820000052452087},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8529999852180481},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9629999995231628},{"id":"https://openalex.org/keywords/tislelizumab","display_name":"tislelizumab","score":0.953000009059906},{"id":"https://openalex.org/keywords/sintilimab","display_name":"sintilimab","score":0.9950000047683716},{"id":"https://openalex.org/keywords/camrelizumab","display_name":"camrelizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/toripalimab","display_name":"toripalimab","score":1.0},{"id":"https://openalex.org/keywords/downstaging","display_name":"downstaging","score":0.6650000214576721},{"id":"https://openalex.org/keywords/surgical-conversion","display_name":"surgical conversion","score":0.796999990940094},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.6480000019073486},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.6200000047683716}],"concepts":[{"id":"https://openalex.org/C2776264508","wikidata":"https://www.wikidata.org/wiki/Q6523413","display_name":"Lenvatinib","level":4,"score":0.8912329077720642},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8884188532829285},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6438562870025635},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.6354670524597168},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6187214851379395},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5426649451255798},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.49572455883026123},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4702771008014679},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40833139419555664},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.37654387950897217},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37205636501312256},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.3545498251914978},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2819173336029053},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.20033207535743713},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.17874538898468018}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2021.751391","doi":"https://doi.org/10.3389/fonc.2021.751391","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2021.751391","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8651538","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8651538/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8651538/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmid:34900698","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34900698","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:cfb2044694e440f68486f97f20618b47","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/cfb2044694e440f68486f97f20618b47","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 11 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2021.751391","doi":"https://doi.org/10.3389/fonc.2021.751391","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2021.751391","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G1589026181","display_name":null,"funder_award_id":"81902405","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"},{"id":"https://openalex.org/G1636929980","display_name":null,"funder_award_id":"No. 82000619","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"},{"id":"https://openalex.org/G5098714535","display_name":null,"funder_award_id":"82000619","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"},{"id":"https://openalex.org/F4320327720","display_name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","ror":null},{"id":"https://openalex.org/F4320327809","display_name":"Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents","ror":null},{"id":"https://openalex.org/F4320338110","display_name":"Science and Technology Department of Zhejiang Province","ror":"https://ror.org/05yj3y977"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3216831771.pdf","grobid_xml":"https://content.openalex.org/works/W3216831771.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W344510317","https://openalex.org/W2028096022","https://openalex.org/W2045836176","https://openalex.org/W2094109552","https://openalex.org/W2109092551","https://openalex.org/W2115261608","https://openalex.org/W2320061744","https://openalex.org/W2502134830","https://openalex.org/W2553739594","https://openalex.org/W2606106498","https://openalex.org/W2766201623","https://openalex.org/W2785838318","https://openalex.org/W2791328450","https://openalex.org/W2810879984","https://openalex.org/W2897581535","https://openalex.org/W2901757914","https://openalex.org/W2921913890","https://openalex.org/W2925446385","https://openalex.org/W2938667209","https://openalex.org/W2946053006","https://openalex.org/W2947955936","https://openalex.org/W2965242861","https://openalex.org/W2967113395","https://openalex.org/W2990602950","https://openalex.org/W3003310139","https://openalex.org/W3022210979","https://openalex.org/W3031297691","https://openalex.org/W3036150446","https://openalex.org/W3045387409","https://openalex.org/W3083986479","https://openalex.org/W3086555948","https://openalex.org/W3124559501","https://openalex.org/W3137429784"],"related_works":["https://openalex.org/W4382657890","https://openalex.org/W3161561893","https://openalex.org/W4288050429","https://openalex.org/W4400415023","https://openalex.org/W4317036844","https://openalex.org/W2977823927","https://openalex.org/W3098108849","https://openalex.org/W4391589932","https://openalex.org/W4322720339","https://openalex.org/W4400415739"],"abstract_inverted_index":{"OBJECTIVE:":[0],"We":[1],"investigated":[2],"lenvatinib":[3,33],"plus":[4,178],"programmed":[5],"cell":[6],"death-1":[7],"(PD-1)":[8],"inhibitors":[9,47,180],"as":[10],"a":[11,113,140,150],"first-line":[12],"treatment":[13],"for":[14],"initially":[15,29,188],"unresectable":[16,30,189],"biliary":[17],"tract":[18],"cancer":[19],"(BTC).":[20],"METHODS:":[21],"In":[22,127],"this":[23],"Phase":[24],"II":[25],"study,":[26],"adults":[27],"with":[28,187],"BTC":[31,190],"received":[32],"(body":[34],"weight":[35],"\u226560":[36],"kg,":[37,41],"12":[38],"mg;":[39],"<60":[40],"8":[42],"mg)":[43,54],"daily":[44],"and":[45,65,83,95,105,144,165,191],"PD-1":[46,179],"(pembrolizumab/tislelizumab/sintilimab/camrelizumab":[48],"200":[49],"mg":[50],"or":[51,118],"toripalimab":[52],"240":[53],"every":[55],"3":[56],"weeks.":[57],"Primary":[58],"endpoints":[59,68],"were":[60],"objective":[61],"response":[62,116,121],"rate":[63,75],"(ORR)":[64],"safety.":[66],"Secondary":[67],"included":[69],"surgical":[70],"conversion":[71],"rate,":[72],"disease":[73],"control":[74],"(DCR),":[76],"event-free":[77],"survival":[78,81],"(EFS),":[79],"overall":[80],"(OS)":[82],"tumor":[84],"biomarkers.":[85],"RESULTS:":[86],"Among":[87],"38":[88],"enrolled":[89],"patients,":[90],"the":[91,96,124,156,166],"ORR":[92],"was":[93,98,159,169,192],"42.1%":[94],"DCR":[97],"76.3%.":[99],"Thirteen":[100],"(34.2%)":[101],"patients":[102,131,186],"achieved":[103,112],"downstaging":[104],"underwent":[106],"surgery,":[107],"six":[108],"of":[109,130,153],"whom":[110],"(46.2%)":[111],"major":[114],"pathologic":[115,120],"(n=2)":[117],"partial":[119],"(n=4)":[122],"in":[123,185],"primary":[125],"tumor.":[126],"total,":[128],"84.2%":[129],"experienced":[132,139],"\u22651":[133],"treatment-related":[134,146],"adverse":[135],"event":[136],"(TRAE),":[137],"34.2%":[138],"Grade":[141],"\u22653":[142],"TRAE":[143],"no":[145],"deaths":[147],"occurred.":[148],"After":[149],"median":[151,157,167],"follow-up":[152],"13.7":[154],"months":[155,161,171],"EFS":[158],"8.0":[160],"(95%":[162,172],"CI:":[163,173],"4.6-11.4)":[164],"OS":[168],"17.7":[170],"not":[174],"estimable).":[175],"CONCLUSIONS:":[176],"Lenvatinib":[177],"showed":[181],"promising":[182],"anti-tumor":[183],"efficacy":[184],"generally":[193],"well":[194],"tolerated.":[195],"CLINICAL":[196],"TRIAL":[197],"REGISTRATION:":[198],"www.chictr.org.cn,":[199],"ChiCTR2100044476.":[200]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3216831771","counts_by_year":[{"year":2026,"cited_by_count":13},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":21},{"year":2023,"cited_by_count":26},{"year":2022,"cited_by_count":13}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2021-12-06T00:00:00"}
